ID DYR23_ECOLX Reviewed; 78 AA. AC P05794; DT 01-NOV-1988, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1988, sequence version 1. DT 03-MAY-2023, entry version 104. DE RecName: Full=Dihydrofolate reductase type 2; DE EC=1.5.1.3; DE AltName: Full=Dihydrofolate reductase type II; OS Escherichia coli. OG Plasmid IncP-beta R751. OC Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; OC Enterobacteriaceae; Escherichia. OX NCBI_TaxID=562; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=3526286; DOI=10.1093/nar/14.14.5933; RA Flensburg J., Steen R.; RT "Nucleotide sequence analysis of the trimethoprim resistant dihydrofolate RT reductase encoded by R plasmid R751."; RL Nucleic Acids Res. 14:5933-5933(1986). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Radstroem P., Sundstroem L., Swedberg G., Flensburg J., Skoeld O.; RL Submitted (MAR-1993) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Thomas C.M.; RL Submitted (AUG-1996) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Key enzyme in folate metabolism. Catalyzes an essential CC reaction for de novo glycine and purine synthesis, and for DNA CC precursor synthesis (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(6S)-5,6,7,8-tetrahydrofolate + NADP(+) = 7,8-dihydrofolate + CC H(+) + NADPH; Xref=Rhea:RHEA:15009, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:57451, ChEBI:CHEBI:57453, ChEBI:CHEBI:57783, CC ChEBI:CHEBI:58349; EC=1.5.1.3; CC -!- PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8- CC tetrahydrofolate from 7,8-dihydrofolate: step 1/1. CC -!- SUBUNIT: Homotetramer. {ECO:0000250}. CC -!- DOMAIN: The active site is situated at the inner surface of a pore CC formed by the four subunits. {ECO:0000250}. CC -!- MISCELLANEOUS: Type II plasmid-specified enzyme is practically CC insensitive to trimethoprim and methotrexate. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X04128; CAA27740.1; -; Genomic_DNA. DR EMBL; X72585; CAA51181.1; -; Genomic_DNA. DR EMBL; U67194; AAC64461.1; -; Genomic_DNA. DR PIR; A23598; RDECD5. DR PIR; S32183; S32183. DR RefSeq; WP_010890144.1; NZ_KU997026.1. DR AlphaFoldDB; P05794; -. DR SMR; P05794; -. DR KEGG; ag:CAA51181; -. DR UniPathway; UPA00077; UER00158. DR GO; GO:0004146; F:dihydrofolate reductase activity; IEA:UniProtKB-EC. DR GO; GO:0006730; P:one-carbon metabolic process; IEA:UniProtKB-KW. DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW. DR GO; GO:0031427; P:response to methotrexate; IEA:UniProtKB-KW. DR GO; GO:0009410; P:response to xenobiotic stimulus; IEA:InterPro. DR GO; GO:0046654; P:tetrahydrofolate biosynthetic process; IEA:UniProtKB-UniPathway. DR Gene3D; 2.30.30.60; -; 1. DR InterPro; IPR009159; Dhfr_type_II. DR InterPro; IPR008990; Elect_transpt_acc-like_dom_sf. DR InterPro; IPR023408; MscS_beta-dom_sf. DR Pfam; PF06442; DHFR_2; 1. DR PIRSF; PIRSF000199; Dhfr_type_II; 1. DR SUPFAM; SSF50090; Electron transport accessory proteins; 1. PE 3: Inferred from homology; KW Antibiotic resistance; Methotrexate resistance; NADP; KW One-carbon metabolism; Oxidoreductase; Plasmid; Trimethoprim resistance. FT CHAIN 1..78 FT /note="Dihydrofolate reductase type 2" FT /id="PRO_0000186437" FT BINDING 32 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250" FT BINDING 66..69 FT /ligand="NADP(+)" FT /ligand_id="ChEBI:CHEBI:58349" FT /evidence="ECO:0000250" FT BINDING 68 FT /ligand="substrate" FT /evidence="ECO:0000250" SQ SEQUENCE 78 AA; 8328 MW; 3D67C2EB67220697 CRC64; MDQHNNGVST LVAGQFALPS HATFGLGDRV RKKSGAAWQG QVVGWYCTKL TPEGYAVESE SHPGSVQIYP VAALERVA //